Response Letter to Pamela E Macintyre's Letter to the Editor.

Autor: Liu S; Faculty of Medicine and Health, School of Pharmacy, The University of Camperdown, Sydney, Australia; Faculty of Medicine and Dentistry, EPICORE Centre, The University of Alberta, Edmonton, Canada. Electronic address: Shania.Liu@sydney.edu.au., Patanwala AE; Faculty of Medicine and Health, School of Pharmacy, The University of Camperdown, Sydney, Australia; Department of Pharmacy, Royal Prince Alfred Hospital, Sydney, Australia., Naylor JM; Whitlam Orthopaedic Research Centre, Ingham Institute, Sydney, Australia; South Western Sydney Clinical School, University of New South Wales, Sydney, Australia., Stevens JA; School of Clinical Medicine, University of New South Wales Medicine and Health, St Vincent's Clinical Campus, University of New South Wales, Sydney, Australia; School of Medicine, University of Notre Dame, Sydney, Australia., Bugeja B; Department of Pain Management, Prince of Wales Hospital, Randwick, Australia., Begley D; Department of Pain Management, Prince of Wales Hospital, Randwick, Australia., Khor KE; Department of Pain Management, Prince of Wales Hospital, Randwick, Australia; Prince of Wales Clinical School, University of New South Wales Medicine and Health, Sydney, Australia., Lau E; Department of Pharmacy, St George Hospital, Kogarah, Australia., Adie S; St George and Sutherland Clinical School, University of New South Wales, Sydney, Australia; St George and Sutherland Centre for Clinical Orthopaedic Research (SCORe), Sydney, Australia., Penm J; Faculty of Medicine and Health, School of Pharmacy, The University of Camperdown, Sydney, Australia; Department of Pharmacy, Prince of Wales Hospital, Randwick, Australia.
Jazyk: angličtina
Zdroj: The journal of pain [J Pain] 2024 Sep; Vol. 25 (9), pp. 104558.
DOI: 10.1016/j.jpain.2024.104558
Abstrakt: Competing Interests: Disclosures The authors (S.L., A.E.P., J.M.N., J.A.S., S.A., J.P.) have received grant funding for an unrelated trial from the Avant Research Foundation. S.L. is supported by an Alberta Innovates Postdoctoral Research Fellowship and a Prince of Wales Hospital Foundation Grant. K.E.K. was invited to a medical advisory committee discussion group on opioid stewardship and tapentadol funded by Seqirus. These funding sources had no role in the content of this response letter.
Databáze: MEDLINE